- Home
- BCC vs RNA Comparison
BCC vs RNA Comparison
Compare BCC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCC
- RNA
- Stock Information
- Founded
- BCC 2004
- RNA 2012
- Country
- BCC United States
- RNA United States
- Employees
- BCC N/A
- RNA N/A
- Industry
- BCC RETAIL: Building Materials
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- BCC Consumer Discretionary
- RNA Health Care
- Exchange
- BCC Nasdaq
- RNA Nasdaq
- Market Cap
- BCC 5.3B
- RNA 5.5B
- IPO Year
- BCC 2013
- RNA 2020
- Fundamental
- Price
- BCC $140.39
- RNA $50.82
- Analyst Decision
- BCC Buy
- RNA Strong Buy
- Analyst Count
- BCC 5
- RNA 9
- Target Price
- BCC $139.60
- RNA $63.22
- AVG Volume (30 Days)
- BCC 259.0K
- RNA 1.0M
- Earning Date
- BCC 11-04-2024
- RNA 11-07-2024
- Dividend Yield
- BCC 0.29%
- RNA N/A
- EPS Growth
- BCC N/A
- RNA N/A
- EPS
- BCC 10.21
- RNA N/A
- Revenue
- BCC $6,801,070,000.00
- RNA $10,117,000.00
- Revenue This Year
- BCC N/A
- RNA $19.85
- Revenue Next Year
- BCC $5.28
- RNA N/A
- P/E Ratio
- BCC $13.74
- RNA N/A
- Revenue Growth
- BCC N/A
- RNA N/A
- 52 Week Low
- BCC $106.38
- RNA $5.68
- 52 Week High
- BCC $154.67
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- BCC 52.71
- RNA 67.90
- Support Level
- BCC $140.83
- RNA $45.65
- Resistance Level
- BCC $145.50
- RNA $56.00
- Average True Range (ATR)
- BCC 4.92
- RNA 2.62
- MACD
- BCC 0.53
- RNA 0.77
- Stochastic Oscillator
- BCC 71.30
- RNA 78.83
About BCC Boise Cascade L.L.C.
Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two segments namely Wood Products and Building Materials Distribution. Wood Products segment manufactures EWP, consisting of laminated veneer lumber (LVL), I-joists, and laminated beams. The Building Materials Distribution segment is engaged in the wholesale of building materials. It distributes products such as plywood, OSB, and lumber items such as siding, doors, metal products, insulation, and roofing, EWP and others. The company generates a majority of its revenue from the Building Material Distribution segment.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.